Lyme disease patients treated for “brain fog” may develop compensatory alterations in white matter that show up on MRI and correspond—unexpectedly—with slow but sound cognitive performance.

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.

Pregnant women who felt stressed by healthcare disruptions caused by the COVID-19 pandemic radiated the unease to their developing offspring. The effects were observable on fetal MRI of both brainstem structure and functional activity.

As chemotherapy treatments improve, patients who respond well may be able to skip surgery with a low chance of recurrence.

When referring physicians agree with radiologists’ recommendations on the clinical necessity of follow-up imaging, three-quarters of patients go on to complete the additional exam.

After programming its EMR to automatically order ultrasound screenings for people at risk of abdominal aortic aneurysms (AAAs), a healthcare system saw a 540% spike in monthly screening exams for the condition over a six-year period.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.